Tiamulin Fumarate Premix Animal Health Medicine
|Payment Type:||L/C,T/T,D/P,Paypal,Money Gram,Western Union|
|Terms of Trade:||FOB,CFR,CIF,EXW,FCA,CPT,CIP|
|Min. Order:||100 Kilogram|
Model No.: TMP06
Tiamulin Fumarate Premix
Best Quality Animal Health Product
This product is white to off-white crystal granular.
Tiamulin Fumarate belongs to pleuromutilin antibiotics, and has bactericidal effect against sensitive bacteria in high concentration. By means of combination with ribosome 50S subunit, Tiamulin Fumarate shall suppress bacteria protein synthesis.
Tiamulin Fumarate has satisfactory anti-microbial activity against mycoplasma and swine treponema hyodysenteriae, and as well as preferable antibacterial activity against most gram-positive bacteria, including staphylococcus, streptococcus(except for group D streptococcus). It also play a role against actinobacillus pleuropneumoniae, and has relatively low antibacterial activity against most gram-negative bacteria.
This product shall be compatible with aureomycin at the ratio of 1:4, and it is treatable to swine bacterial enteritis, bacterial pneumonia, treponema-caused swine dysentery. It also has remarkable effect on mycoplasma pneumonia, and pneumoniacaused by combination infection of bordetella bronchisepticaand pasteurella multocida.
Significant absorption effect for swine oral administration. Bioacailability is about 85% after single dose administration, and peak serum concentration occur after 2~4 hours. And drug is wide spreading in animal body, and the highest density comes up at lung tissue. Tiamulin Fumarate is broadly metabolized in animal body, then turns into more than 20 kinds of metabolites, some of which has antibacterial activity. And Tiamulin Fumarate metabolites is mainly excreted as feces via bile, and about 30% excreted as urine.
(1) Feeding together with polyether antibiotics, such as Monensin, Salinomycin, and Narasin, etc, will give rise to slow growth, ataxia, paralytic syndromes, even death.
(2) If use together with other ribosome 50S subunit-combining antibiotics(such as macrolides antibiotics, lincomycin), drug function will be reduced due to their competition on same action site.
[Effect and function]
Pleuromutilin antibiotics. It is mainly used as precaution and treatment for swine mycoplasma pneumonia, actinobacillus pleuropneumoniae, and swine dysentery caused by treponema.
[Usage and dosage]
Premix 10%: Calculated based on this product.
Mixed in feedstuff: every 1000kg feedstuff, 400~1000g for swine, continuous use for 5~10 days.
Premix 80%: Calculated based on this product.
Mixed in feedstuff: every 1000kg feedstuff, 50~125g for swine, continuous use for 5~10 days.
Normal dosage for swine, sometimes skin erythema occurs. If over-dosed, it might cause swine short salivation, vomit and central nervous depressant.
(1) Forbidden to use together with polyether antibiotics, such as Monensin, Salinomycin, and Narasin, etc.
(2) Avoid exposure to eye and skin.
(3) If environment temperature is above 40℃, feedstuff mixed with this product shall be stored within 7 days.
7 days for swine.
25kg/bag (Premix 10%), 20kg/drum (Premix 80%)
Keep airtight and shading in a dry place at room temperature.
Shandong Shengli Bioengineering Co., Ltd
Shandong Shengli Bioengineering Co., Ltd (Abbreviation: SHENGLI) is a joint venture built by China Animal Husbandry Industry Company Limited (Abbreviation: CAHIC) and Shandong Shengli Corporation Limited. And originally built in 2004 with total investment of RMB 500 million, and guided by bio-fermentation technology, producing animal-specific antibiotic API, Veterinary preparations and feed additives. Also, it is national high-tech enterprise, and regarded as top 10 veterinary drug enterprise in Shandong province and top 10 in national veterinary drug industry in China. Shengli is located in No.118, High-tech zone, Jining city, Shandong province, China. And it has covered an area of 70 acres, and equipped with 1st class facility as well as advanced management. Currently Shengli primarily manufactures feed additives, such as Enramycin, Bambermycin, Hainanmycin, Nosiheptide, Monensin and Salinomycin, also veterinary drugs as Tiamulin Fumarate, Florfenicol, Tilmicosin, Doxycycline Hydrochloride, etc. And Shengli is global leader on Tiamulin Fumarate and Bambermycin production and sales, also the professional manufacturer in the globe that own China self-owned intellectual property on Hainanmycin sodium API & Premix. Shengli possesses complete veterinary drug workshop and production line that passes US FDA and CHINA GMP authentication, and there are production equipments of first-rate and high level automation that manufacture various animal-specific drugs. In strict accordance with current GMP standard in EU and USA, we have been establishing and improving quality control system, and our product have been registered and authenticated in dozens of countries and areas overseas. Among all products, Tiamulin Fumarate API has been awarded EU COS certificate in the lead; Tiamulin Fumarate Premix 80% have required Japan FMA certificate; Premix of Tiamulin Fumarate and that of Bambermycin, Monensin, Salinomycin have achieved Australia APVMA authentication. And we possess self-owned intellectual property patent in China concerning Enramycin and Avilamycin, and our products are sold well both at home and abroad. Shengli values research and re-innovation on technology import, and set up Cahic-Shengli R&D Institute, and Shengli has required many national patent and scientific achievements while positively establishing cooperation with peers and professionals domestic and overseas. Shengli always adhere to the management principle of [Success on quality, Sharing on profit, and all win on prosperity". We stick to contract-honoring and promise-keeping, with high brand reputation, and have built well-rounded marketing network domestic and overseas. Sincerely hope to establish new type of friendly relations and mutual development cooperation with clients.
- Company Name: Shandong Shengli Bioengineering Co., Ltd
- Representative: Zhang Zhenghai
- Product/Service: Tiamulin Fumarate , Tylvalosin Tartrate , Florfenicol Powder , Spectinomycin And Lincomycin , Hainanmycin Sodium , Doxycycline Hyclate Soluble Powder
- Capital (Million US $): 200000000RMB
- Year Established: 2004
- Total Annual Sales Volume (Million US $): US$50 Million - US$100 Million
- Export Percentage: 51% - 60%
- Total Annual Purchase Volume (Million US $): Below US$1 Million
- No. of Production Lines: 10
- No. of R&D Staff: 51 -60 People
- No. of QC Staff: 51 -60 People
- OEM Services Provided: yes
- Factory Size (Sq.meters): 30,000-50,000 square meters
- Factory Location: No.118, Tongji Road, High-tech Zone, Jining, Shandong, China
- Contact Person: Ms. Sun
- Tel: 86-537-2481087
Premium Related Products